Inhibitor - PDFSEARCH.IO - Document Search Engine

Inhibitor
Results: 3217

#	Item
321	Interim Results from SAILING Study, One of the Phase III Studies of the Integrase Inhibitor “Dolutegravir”, Disclosed by ViiV Healthcare Osaka, Japan, March 7, Shionogi & Co., Ltd. (Head Office: Osaka; Preside Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:24 Organic chemistry Medicine Amides Merck Oxadiazoles Raltegravir Integrase Dolutegravir ViiV Healthcare Integrase inhibitors Chemistry Organofluorides
322	Avaxia Biologics Receives FDA Orphan Drug Designation for AVX-470 for the Treatment of Pediatric Ulcerative Colitis LEXINGTON, Mass. – November 21, 2014 – Avaxia Biologics, Inc., a clinical-stage biopharmaceutical co Add to Reading List Source URL: www.avaxiabiologics.com Language: English - Date: 2014-11-21 11:16:42 Immunology Monoclonal antibodies Pharmacology Abdominal pain Inflammatory bowel disease TNF inhibitor Ulcerative colitis Biologic Monoclonal antibody therapy Medicine Health Autoimmune diseases
323	ESMOTSR-011, A Potent ALK Inhibitor with Clinical Activity in Phase I/IIa Development Glen J Weiss1, Jasgit C Sachdev2, Jeffrey R Infante3, Monica Mita4, Keith M Wilcoxen5, Vikram Kansra5, David G Brooks5, Robert Add to Reading List Source URL: www.tesarobio.com Language: English - Date: 2013-09-27 12:02:35 Organofluorides Chemistry Crizotinib Piperidines Pyrazoles Pyridines ALK inhibitor Anaplastic lymphoma kinase Non-small-cell lung carcinoma Medicine Oncology Lung cancer
324	Avaxia CEO Barbara Fox is Named an EY Entrepreneur Of The Year™ 2014 Award Finalist in New England Add to Reading List Source URL: www.avaxiabiologics.com Language: English - Date: 2014-05-22 11:31:36 Pharmacology Monoclonal antibodies Immune system Immunology Ulcerative colitis TNF inhibitor Mucositis Inflammatory bowel disease Biologic Medicine Health Autoimmune diseases
325	ViiV Healthcare Receives EU marketing authorization for Triumeq®, a Single-pill Regimen Containing the Integrase Inhibitor “Dolutegravir” Osaka, Japan, September 4, Shionogi & Co., Ltd. (Head Office: Osaka; P Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2015-01-27 14:49:56 Integrase inhibitors Abacavir Cyclopropanes Purines Antiretroviral drug HIV/AIDS Lamivudine Reverse-transcriptase inhibitor ViiV Healthcare Biology Chemistry Organofluorides
326	PDF Document Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:09 ViiV Healthcare Intel Viiv Prescription Drug User Fee Act Shionogi Integrase inhibitor Food and Drug Administration Integrase Pharmaceutical sciences Pharmacology Clinical research
327	The School Nurses’ Prescription News You Can Use from Your Indiana Poison Center Top Five Calls From School Nurses in 2013 In 2013, the last year for which complete data was available, Indiana Poison Center (IPC) recei Add to Reading List Source URL: www.indianapoison.org Language: English - Date: 2014-11-20 10:13:09 Amphetamines Nootropics Amines Alcohols Stimulants Methylphenidate Citalopram Selective serotonin reuptake inhibitor Ibuprofen Chemistry Organic chemistry Pharmacology
328	PDF Document Add to Reading List Source URL: www.avaxiabiologics.com Language: English - Date: 2014-05-01 16:01:22 Anatomy Immunology Abdominal pain Biotechnology Immune system Inflammatory bowel disease Ulcerative colitis TNF inhibitor Colitis Medicine Health Autoimmune diseases
329	The School Nurses’ Prescription News You Can Use from Your Indiana Poison Center Top Five Calls From School Nurses in 2013 In 2013, the last year for which complete data was available, Indiana Poison Center (IPC) recei Add to Reading List Source URL: indianapoison.trendyminds.com Language: English - Date: 2014-11-20 10:13:09 Amphetamines Nootropics Amines Alcohols Stimulants Methylphenidate Citalopram Selective serotonin reuptake inhibitor Ibuprofen Chemistry Organic chemistry Pharmacology
330	Avaxia Biologics Awarded Patent with Broad Coverage over Oral Anti-TNF Antibodies for Inflammatory Bowel Disease LEXINGTON, Mass. – February 11, 2014 – Avaxia Biologics, Inc., a clinical-stage biopharmaceutical compa Add to Reading List Source URL: www.avaxiabiologics.com Language: English - Date: 2014-02-11 13:20:44 Gastroenterology Monoclonal antibodies Abdominal pain Immunology Immunosuppressants Inflammatory bowel disease TNF inhibitor Ulcerative colitis Biologic Medicine Health Autoimmune diseases

UPDATE